Scienmag

MARCH 15, 2021

For their study, the team led by bioinformatics professor Andreas Keller and his doctoral student […]. Credit: Oliver Dietze In their study, which is now published in the journal Nature Aging, they show that the level of non-coding RNAs in the blood of a Parkinson’s patient can be used to track the course of the disease.

Bioinformatics 92

Bioinformatics Doctors Doctor Genetics 92

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. According to an article by Stephens, Zachary D.,

Bioinformatics 59

Bioinformatics Drugs Genomics Genome 59

XTalks

APRIL 21, 2023

Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS. Ultima Genomics will provide their high-throughput NGS instrument platform, the UG 100, and Genome Insight will provide the bioinformatics platform for data analysis.

Genomics 97

Genomics Genome Bioinformatics Genetics 97

pharmaphorum

APRIL 1, 2021

They go into bioinformatics”. But with a host of well-educated doctors, biologists, engineers and software developers in the country, this gap has been filled by a strong digital health ecosystem. They go into bioinformatics.”. So what do they do? Using the terabytes of data, such experiments can be produced.

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

XTalks

MAY 20, 2022

Doctors and physicians rely on the results provided by a clinical scientist to make an accurate prognosis, diagnosis and assessment for a patient’s treatment plan. Interpret medical tests and confer with doctors and physicians for a suitable prognosis and treatment plan. Their work might involve matching blood samples for transfusions.

Scientist 105

Scientist Life Science Clinical Research Doctor 105

STAT News

MARCH 6, 2023

Determined to prove his doctors wrong, Aldrich got his tumor genetically sequenced and arranged for a German biotech, CeGaT, to design an experimental neoantigen vaccine that he received in 2019, according to Jacobs and an account Aldrich gave to an online cancer publication. “It really was a choice of this or nothing.”

Vaccine 98

Vaccine Vaccination Drugs Clinical Trials 98